Page last updated: 2024-11-04

sulfasalazine and Lymphoma, Follicular

sulfasalazine has been researched along with Lymphoma, Follicular in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Lymphoma, Follicular: Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toyoda, H1
Yamaguchi, M1
Uemura, Y1
Mukai, K1
Sawa, H1
Suzuki, H1
Shiku, H1

Other Studies

1 other study available for sulfasalazine and Lymphoma, Follicular

ArticleYear
Successful treatment of lymphoid follicular proctitis with sulfasalazine suppositories.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colonoscopy; Diagnosis, Differential; Female; Human

2000